Organic Letters
X-ray crystallographic data for 3a (CIF)
Letter
propargylation reactions of ketones and imines, see: Wisniewska, H. M.;
Jarvo, E. R. J. Org. Chem. 2013, 78, 11629.
X-ray crystallographic data for 3f (CIF)
X-ray crystallographic data for 3h (CIF)
X-ray crystallographic data for 5b (CIF)
X-ray crystallographic data for 5c (CIF)
Experimental procedures and characterization data for all
(10) For catalyst-controlled, enantioselective propargylation of imines,
see:(a)Kagoshima, H.;Uzawa,T.;Akiyama, T.Chem. Lett.2002,31,298.
(b) Wisniewska, H. M.; Jarvo, E. R. Chem. Sci. 2011, 2, 807. (c) Vieira, E.
M.; Haeffner, F.; Snapper, M. L.; Hoveyda, A. H. Angew. Chem., Int. Ed.
2012, 51, 6618.
(11) For examples of diastereoselective propargylation of imines, see:
(a)Gonzalez,A.Z.;Soderquist,J.A.Org.Lett.2007,9,1081.(b)Fandrick,
D. R.;Johnson, C. S.;Fandrick, K. R.;Reeves, J. T.;Tan, Z.;Lee, H.;Song,
J. J.; Yee, N. K.; Senanayake, C. H. Org. Lett. 2010, 12, 748. (c) García-
AUTHOR INFORMATION
Corresponding Author
■
Munoz, M. J.; Zacconi, F.; Foubelo, F.; Yus, M. Eur. J. Org. Chem. 2013,
̃
2013, 1287. (d) Guo, T.; Song, R.; Yuan, B.-H.; Chen, X.-Y.; Sun, X.-W.;
Lin,G.-Q.Chem.Commun.2013,49,5402.(e)Chen,D.;Xu,M.-H.Chem.
Commun. 2013, 49, 1327.
Notes
The authors declare no competing financial interest.
(12)Kohn, B.L.;Ichiishi,N.;Jarvo, E. R.Angew. Chem., Int.Ed. 2013,52,
4414.
(13)Forsilver-catalyzedenantioselectiveallylationreactionsofketones,
see: Wadamoto, M.; Yamamoto, H. J. Am. Chem. Soc. 2005, 127, 14556.
(14) Formation of silver phosphine complexes in methanol followed by
solvent replacement with THF is employed in related transformations.
See refs 10b 12, and 13.
ACKNOWLEDGMENTS
■
Thisworkwassupported byNIHNCI(F31CA177212 toC.A.O)
and DoEd GAANN (PA200A120070 to T.B.D.E). We thank Dr.
Daniel Fandrick (Boehringer Ingelheim) for helpful discussions
regarding the synthesis of propargylboronic acid pinacol ester 12.
Dr. Joseph Ziller and Jordan Corbey (University of California,
Irvine) are acknowledged for X-ray crystallography data. Dr. John
GreavesandDr.BeniamBerhane(UniversityofCalifornia,Irvine)
are acknowledged for mass spectrometry data.
(15) Kohn, B. L.; Jarvo, E. R. Org. Lett. 2011, 13, 4858.
(16) For supplementary crystallographic data, see the Supporting
(17) For supplementary crystallographic data, see the Supporting
(18) Diver, S. T.; Giessert, A. J. Chem. Rev. 2004, 104, 1317.
(19) For enantioselective allylation of alkyl cyclic N-sulfonylketimines,
see: Hepburn, H. B.; Chotsaeng, N.; Luo, Y.; Lam, H. W. Synthesis 2013,
45, 2649.
REFERENCES
■
(1) Ninety-four of the top 200 pharmaceuticals by U.S. retail sales in
2012 contained functional groups that could be prepared from α-chiral
amines, while 25 of the top 200 pharmaceuticals contained α-chiral
amines. See: (a) Njardarson Group. Top Pharmaceuticals Poster. http://
2015). (b) McGrath, N. A.; Brichacek, M.; Njardarson, J. T. J. Chem.
Educ. 2010, 87, 1348.
(2) For reviews on catalytic enantioselective methods for generating
chiralamines,see:(a)Nugent,T.C.;El-Shazly,M.Adv.Synth.Catal.2010,
352,753.(b)Kobayashi,S.;Mori,Y.;Fossey,J.S.;Salter,M.M.Chem.Rev.
2011, 111, 2626.
(20) For a discussion of these mechanistic possibilities, including
representative examples, see ref 9a,b.
(21) Propargyl borolane 12 and allenyl borolane 2 can undergo base-
catalyzed equilibration, favoring allenyl borolane 2. However, in control
experiments, we have determined that under the propargylation reaction
conditions(8%KOt-Bu,DMF,6h)intheabsenceofsilvercatalystthereis
noequilibrationbetween12and2.SeetheSupportingInformationforfull
details.
(22) For selected examples of reactions that likely proceed through a
similarmechanism,see:(a)Tamaru,Y.;Goto,S.;Tanaka,A.;Shimizu,N.;
Kimura, M. Angew. Chem., Int. Ed. Engl. 1996, 35, 878. (b) Hameury, T.;
Guillemont, J.; Van Hijfte, L.; Bellosta, V.; Cossy, J. Org. Lett. 2009, 11,
2397. (c) Fandrick, D. R.;Saha, J.; Fandrick, K. R.;Sanyal, S.; Ogikubo, J.;
Lee, H.; Roschangar, F.; Song, J. J.; Senanayake, C. H. Org. Lett. 2011, 13,
5616. (d) Fandrick, K. R.; Ogikubo, J.; Fandrick, D. R.; Patel, N. D.; Saha,
J.; Lee, H.; Ma, S.; Grinberg, N.; Busacca, C. A.; Senanayake, C. H. Org.
Lett. 2013, 15, 1214. (e)Mszar, N. W.;Haeffner, F.;Hoveyda, A. H. J. Am.
Chem. Soc. 2014, 136, 3362.
(23) For selected examples of isomerization of allenyl- and
propargylmetal complexes, see: (a) Elsevier, C. J.; Kleijn, H.; Boersma,
J.;Vermeer,P.Organometallics1986,5,716.(b)Ogoshi,S.;Fukunishi,Y.;
Tsutsumi, K.; Kurosawa, H. J. Chem. Soc., Chem. Commun. 1995, 2485.
(c) Ogoshi, S.; Nishida, T.; Fukunishi, Y.; Tsutsumi, K.; Kurosawa, H. J.
Organomet. Chem. 2001, 620, 190.
(24) For examples in the context of palladium-catalyzed cross-coupling
reactions, see: (a) Moriya, T.; Miyaura, N.; Suzuki, A. Synlett 1994, 1994,
149. (b) Ma, S.; Zhang, A. J. Org. Chem. 2002, 67, 2287. (c) Marshall, J. A.
Chem. Rev. 2000, 100, 3163.
(3) For a discussion and review, see: Riant, O.; Hannedouche, J. Org.
Biomol. Chem. 2007, 5, 873.
(4) For a lead reference, see: Yin, L.; Otsuka, Y.; Takada, H.; Mouri, S.;
Yazaki, R.; Kumagai, N.; Shibasaki, M. Org. Lett. 2013, 15, 698.
(5) (a) For enantioselective hydrogenation, see: Oppolzer, W.; Wills,
M.; Starkemann, C.; Bernardinelli, G. Tetrahedron Lett. 1990, 31, 4117.
(b) Forhomoenolateadditions, see:Rommel, M.;Fukuzumi, T.;Bode, J.
W.J. Am. Chem. Soc. 2008,130, 17266. (c) Forenantioselective arylation,
see:Nishimura, T.; Noishiki, A.;Tsui, G. C.;Hayashi, T. J. Am. Chem. Soc.
2012, 134, 5056. (d) For formal [3 + 2] cycloadditions with TMM, see:
Trost, B. M.; Silverman, S. M. J. Am. Chem. Soc. 2012, 134, 4941.
(6) Synthesis of N-sulfonylketimines from saccharin: Davis, F. A.;
Towson, J. C.; Vashi, D. B.; ThimmaReddy, R.; McCauley, J. P., Jr.;
Harakal, M. E.; Gosciniak, D. J. J. Org. Chem. 1990, 55, 1254.
(7) For enantioselective arylation, see: (a) Jiang, C.; Lu, Y.; Hayashi, T.
Angew. Chem., Int. Ed. 2014, 53, 9936. (b) Yang, G.; Zhang, W. Angew.
Chem., Int. Ed. 2013, 52, 7540. (c) Wang, H.; Jiang, T.; Xu, M.-H. J. Am.
Chem. Soc. 2013, 135, 971. (d) Jiang, T.; Wang, Z.; Xu, M.-H. Org. Lett.
2015, 17, 528. (e) For enantioselective allylation, see: Luo, Y.; Hepburn,
H.B.;Chotsaeng,N.;Lam,H.W.Angew.Chem.,Int.Ed.2012,51,8309.(f)
For enantioselective alkenylation, see: Luo, Y.; Carnell, A. J.; Lam, H. W.
Angew. Chem., Int. Ed. 2012, 51, 6762.
(25) This strategy has been employed by Fandrick and co-workers. See
ref22c.Arelatedstrategyhasbeenemployedtoelucidatethemechanistic
details of transition-metal-catalyzed allylation reactions. See: (a)
Reference 22c. (b) Shaghafi, M. B.; Kohn, B. L.; Jarvo, E. R. Org. Lett.
2008, 10, 4743.
(8) Forrecentexamples insynthesis ofpolyketides, see:(a) Mailhol, D.;
Willwacher, J.; Kausch-Busies, N.; Rubitski, E. E.; Sobol, Z.; Schuler, M.;
Lam, M.-H.; Musto, S.; Loganzo, F.; Maderna, A.; Furstner, A. J. Am.
Chem. Soc. 2014, 136, 15719. (b) Reznik, S. K.; Marcus, B. S.; Leighton, J.
L. Chem. Sci. 2012, 3, 3326.
(26) See the Supporting Information for full experimental details.
̈
(9) (a) For a comprehensive review, see: Ding, C.-H.; Hou, X.-L. Chem.
Rev. 2011, 111, 1914. (b) For a synopsis of catalytic enantioselective
D
Org. Lett. XXXX, XXX, XXX−XXX